About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Rapid Diagnostic Assay for Gonorrhea and Chlamydia | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05564299

Rapid Diagnostic Assay for Gonorrhea and Chlamydia

This study is a pilot randomized controlled trial evaluating the use of either a) rapid 30-minute desktop assay or b) point-of-care gram stain (current standard of care) to guide the clinical manageme...

Lead sponsor: Massachusetts General Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Massachusetts General Hospital

Collaborators

American Sexually Transmitted Diseases Association

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 years of age and older
•Presenting with symptoms of acute urethritis or cervicitis
•Willing to provide urine or additional vaginal swab specimen

Exclusion Criteria

•Younger than 18 years old
•Presenting with symptoms not consistent with urethritis or cervicitis
•Unwilling or unable to provide urine or vaginal swab specimen
•Pregnant
•Contact of index patients with Gonorrhea or Chlamydia
•Known exposure to Gonorrhea or Chlamydia
•Reporting concurrent symptoms at a non-genital site
•Suspected or confirmed to have Monkeypox

Related studies

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

NCT07509853 · HIV Prevention, Substance Use, and more

Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study

NCT07512869 · HIV Prevention, Substance Use, and more

RECRUITINGPhase 2

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

NCT07088419 · Mycoplasma Genitalium, Non-gonococcal Urethritis (NGU)

RECRUITINGPhase 3

STI Testing to Enhance PrEP Use in Pregnancy

NCT06919614 · PrEP Adherence, Sexually Transmitted Infections (STIs), and more

Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

NCT06860945 · Sexually Transmitted Infections (STIs), HIV, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 23, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment98

Start dateMar 2023

Last updatedSep 23, 2025

Condition

Urethritis Cervicitis Sexually Transmitted Infections

Locations shown

Massachusetts General Hospital

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 23, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions